Fredrick Wigley
Associate Director, Division of Rheumatology · Johns Hopkins University School of Medicine
Credentials: · · · ·
History
- Present
Johns Hopkins Scleroderma Center · Johns Hopkins University School of Medicine
- 1975–1977
- 1972–1975
Internal Medicine
Research
Cyclophosphamide versus placebo in scleroderma lung disease
New England Journal of Medicine · 2006 · 1,231 citations
The Lancet Respiratory Medicine · 2016 · 831 citations
Annals of Internal Medicine · 2000 · 798 citations
81 papers · 1 as a fellow
63 papers
47 papers
36 papers
30 papers
28 papers
- FB
27 papers
25 papers
Grants
- 2003–2018
Multidisciplinary Rheumatology Training Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases · T32
Contact PI · $1.1M · Johns Hopkins University
- 2006–2014
Molecular Determinants of Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · P50
Project lead · $2.1M · Johns Hopkins University
- 1998–2004
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $202.8K · Johns Hopkins University
- 1999–2000
Planning Grant for Multipurpose Clinical Research Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P20
Contact PI · $164K · Johns Hopkins University
Clinical trials
- 2007–2012
A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Principal investigator · Completed · Phase 3
Johns Hopkins University
- 2001–2010
High Dose Cyclophosphamide for Treatment of Scleroderma
Principal investigator · Completed · Phase 3
Johns Hopkins University